AI assistant
Sending…
Indaptus Therapeutics, Inc. — Director's Dealing 2021
Dec 9, 2021
35475_dirs_2021-12-08_c4203dfd-1b45-407c-b2e0-40119dea65aa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Indaptus Therapeutics, Inc. (INDP)
CIK: 0001857044
Period of Report: 2021-12-01
Reporting Person: Gilbert Mark John (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-12-01 | Stock Option (right to buy) | $5.35 | A | 20000 | Acquired | 2031-12-01 | Common Stock (20000) | Direct |
Footnotes
F1: One hundred percent of the stock options vest and become exercisable on December 1, 2022.
More from Indaptus Therapeutics, Inc.
Interim / Quarterly Report
2026
May 15
Report Publication Announcement
2026
May 15
Board/Management Information
2026
Apr 23
Board/Management Information
2026
Apr 3
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Feb 27
Regulatory Filings
2026
Feb 27
Director's Dealing
2026
Feb 13
Capital/Financing Update
2026
Feb 12
Director's Dealing
2026
Jan 23